Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
"You Cannot Teach Someone How to be an MSL"
Summary
In this episode, Kathleen Bailey joins Tom Caravela to explore the essential skills for Medical Science Liaisons (MSLs). They highlight the importance of communication, trust-building, and soft skills, along with strategies for real-time problem-solving and handling objections. Kathleen shares insights on managing unknown questions, the value of mentorship, and drug launch stages. She also offers tips for mastering scientific knowledge, staying updated, and the role of motivation in an MSL career. The episode wraps up with effective KOL engagement strategies and key takeaways.
Kathleen Bailey, Medical Science Liaison at Scynexis discusses what aspects can be taught to MSLs and what needs to be learned through experience.
Kathleen shares…
π What aspects of the MSL role can be taught
π What aspects of the MSL role cannot be taught and need to be learned
π Best practices for bridging the gap
π Advice on how to find success and improve performance
Medical Science Liaison, MSL skills, KOL engagement strategies, MSL career tips, drug launch stages
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary